BridgeBio Pharma, Inc.
BBIONASDAQ
Healthcare
Biotechnology
$73.22
-1.23(-1.6%)
52W $30.14 – $79.91
Quick:
SCHEDULE 13D/A
Apr 2, 2026 (4 days ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Mar 30, 2026 (1 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Feb 24, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Feb 24, 2026 (1 months ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
SCHEDULE 13D/A
Feb 17, 2026 (1 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
SCHEDULE 13G
Feb 17, 2026 (1 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Feb 12, 2026 (1 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 21, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 12, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G
Nov 14, 2025 (4 months ago)Beneficial Ownership
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13D/A
Nov 14, 2025 (4 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
10-Q
Oct 29, 2025 (5 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Oct 29, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 29, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Oct 27, 2025 (5 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13D/A
Aug 14, 2025 (7 months ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
10-Q
Aug 5, 2025 (8 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 5, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Jul 29, 2025 (8 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
8-K
Jul 2, 2025 (9 months ago)Current Report
Material event disclosure
Event materiality and market reaction